Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2009

Open Access 01-12-2009 | Original investigation

Divergent fifteen-year trends in traditional and cardiometabolic risk factors of cardiovascular diseases in the Seychelles

Authors: Pascal Bovet, Sarah Romain, Conrad Shamlaye, Shanti Mendis, Roger Darioli, Walter Riesen, Luc Tappy, Fred Paccaud

Published in: Cardiovascular Diabetology | Issue 1/2009

Login to get access

Abstract

Objective

Few studies have assessed secular changes in the levels of cardiovascular risk factors (CV-RF) in populations of low or middle income countries. The systematic collection of a broad set of both traditional and metabolic CV-RF in 1989 and 2004 in the population of the Seychelles islands provides a unique opportunity to examine trends at a fairly early stage of the "diabesity" era in a country in the African region.

Methods

Two examination surveys were conducted in independent random samples of the population aged 25–64 years in 1989 and 2004, attended by respectively 1081 and 1255 participants (participation rates >80%). All results are age-standardized to the WHO standard population.

Results

In 2004 vs. 1989, the levels of the main traditional CV-RF have either decreased, e.g. smoking (17% vs. 30%, p < 0.001), mean blood pressure (127.8/84.8 vs. 130.0/83.4 mmHg, p < 0.05), or only moderately increased, e.g. median LDL-cholesterol (3.58 vs. 3.36 mmol/l, p < 0. 01). In contrast, marked detrimental trends were found for obesity (37% vs. 21%, p < 0.001) and several cardiometabolic CVD-RF, e.g. mean HDL-cholesterol (1.36 vs. 1.40 mmol/l, p < 0.05), median triglycerides (0.80 vs. 0.78 mmol/l, p < 0.01), mean blood glucose (5.89 vs. 5.22 mmol/l, p < 0.001), median insulin (11.6 vs. 8.3 μmol/l, p < 0.001), median HOMA-IR (2.9 vs. 1.8, p < 0.001) and diabetes (9.4% vs. 6.2%, p < 0.001). At age 40–64, the prevalence of elevated total cardiovascular risk tended to decrease (e.g. WHO-ISH risk score ≥10; 11% vs. 13%, ns), whereas the prevalence of the metabolic syndrome (which integrates several cardiometabolic CVD-RF) nearly doubled (36% vs. 20%, p < 0.001). Data on physical activity and on intake of alcohol, fruit and vegetables are also provided. Awareness and treatment rates improved substantially for hypertension and diabetes, but control rates improved for the former only. Median levels of the cardiometabolic CVD-RF increased between 1989 and 2004 within all BMI strata, suggesting that the worsening levels of cardiometabolic CVD-RF in the population were not only related to increasing BMI levels in the interval.

Conclusion

The levels of several traditional CVD-RF improved over time, while marked detrimental trends were observed for obesity, diabetes and several cardiometabolic factors. Thus, in this population, the rapid health transition was characterized by substantial changes in the patterns of CVD-RF. More generally, this analysis suggests the importance of surveillance systems to identify risk factor trends and the need for preventive strategies to promote healthy lifestyles and nutrition.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001, 104: 2746-2753. 10.1161/hc4601.099487.CrossRefPubMed Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001, 104: 2746-2753. 10.1161/hc4601.099487.CrossRefPubMed
2.
go back to reference Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006, 367: 1747-1757. 10.1016/S0140-6736(06)68770-9.CrossRefPubMed Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006, 367: 1747-1757. 10.1016/S0140-6736(06)68770-9.CrossRefPubMed
3.
go back to reference Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K: The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007, 370: 1929-1938. 10.1016/S0140-6736(07)61696-1.CrossRefPubMed Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K: The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007, 370: 1929-1938. 10.1016/S0140-6736(07)61696-1.CrossRefPubMed
4.
go back to reference Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Solberg LI: Prioritizing Clinical Preventive Services: A Review and Framework with Implications for Community Preventive Services. Annu Rev Public Health. 2009. Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Solberg LI: Prioritizing Clinical Preventive Services: A Review and Framework with Implications for Community Preventive Services. Annu Rev Public Health. 2009.
5.
go back to reference Kottke TE, Faith DA, Jordan CO, Pronk NP, Thomas RJ, Capewell S: The comparative effectiveness of heart disease prevention and treatment strategies. Am J Prev Med. 2009, 36: 82-88. 10.1016/j.amepre.2008.09.010.CrossRefPubMed Kottke TE, Faith DA, Jordan CO, Pronk NP, Thomas RJ, Capewell S: The comparative effectiveness of heart disease prevention and treatment strategies. Am J Prev Med. 2009, 36: 82-88. 10.1016/j.amepre.2008.09.010.CrossRefPubMed
6.
go back to reference Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, Dyer AR, Liu K, Greenland P: Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA. 1999, 282: 2012-2018. 10.1001/jama.282.21.2012.CrossRefPubMed Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, Dyer AR, Liu K, Greenland P: Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA. 1999, 282: 2012-2018. 10.1001/jama.282.21.2012.CrossRefPubMed
7.
go back to reference Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004, 364: 937-952. 10.1016/S0140-6736(04)17018-9.CrossRefPubMed Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004, 364: 937-952. 10.1016/S0140-6736(04)17018-9.CrossRefPubMed
8.
go back to reference Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, Damasceno A, Ounpuu S, Yusuf S, INTERHEART Investigators in Africa: Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation. 2005, 112: 3554-3561. 10.1161/CIRCULATIONAHA.105.563452.CrossRefPubMed Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, Damasceno A, Ounpuu S, Yusuf S, INTERHEART Investigators in Africa: Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation. 2005, 112: 3554-3561. 10.1161/CIRCULATIONAHA.105.563452.CrossRefPubMed
9.
go back to reference Iestra JA, Kromhout D, Schouw van der YT, Grobbee DE, Boshuizen HC, van Staveren WA: Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation. 2005, 112: 924-934. 10.1161/CIRCULATIONAHA.104.503995.CrossRefPubMed Iestra JA, Kromhout D, Schouw van der YT, Grobbee DE, Boshuizen HC, van Staveren WA: Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation. 2005, 112: 924-934. 10.1161/CIRCULATIONAHA.104.503995.CrossRefPubMed
10.
go back to reference Khaw KT, Wareham N, Bingham S, Welch A, Luben R, Day N: Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med. 2008, 5: e12-10.1371/journal.pmed.0050012.PubMedCentralCrossRefPubMed Khaw KT, Wareham N, Bingham S, Welch A, Luben R, Day N: Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med. 2008, 5: e12-10.1371/journal.pmed.0050012.PubMedCentralCrossRefPubMed
11.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F, American Heart Association; National Heart, Lung and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F, American Heart Association; National Heart, Lung and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed
12.
go back to reference Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988, 37: 1595-1607. 10.2337/diabetes.37.12.1595.CrossRefPubMed Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988, 37: 1595-1607. 10.2337/diabetes.37.12.1595.CrossRefPubMed
13.
go back to reference Ferrannini E, Haffner SM, Mitchell BD, Stern MP: Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991, 34: 416-422. 10.1007/BF00403180.CrossRefPubMed Ferrannini E, Haffner SM, Mitchell BD, Stern MP: Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991, 34: 416-422. 10.1007/BF00403180.CrossRefPubMed
14.
go back to reference Chronic diseases and health promotion – STEPwise approach to surveillance (STEPS). 2009, Geneva: WHO Chronic diseases and health promotion – STEPwise approach to surveillance (STEPS). 2009, Geneva: WHO
15.
go back to reference The WHO Global InfoBase. 2009, Geneva: World Health Organization The WHO Global InfoBase. 2009, Geneva: World Health Organization
16.
go back to reference Vlasoff T, Laatikainen T, Korpelainen V, Uhanov M, Pokusajeva S, Rogacheva A, Tossavainen K, Vartiainen E, Puska P: Ten year trends in chronic disease risk factors in the Republic of Karelia, Russia. Eur J Public Health. 2008, 18: 666-673. 10.1093/eurpub/ckn063.CrossRefPubMed Vlasoff T, Laatikainen T, Korpelainen V, Uhanov M, Pokusajeva S, Rogacheva A, Tossavainen K, Vartiainen E, Puska P: Ten year trends in chronic disease risk factors in the Republic of Karelia, Russia. Eur J Public Health. 2008, 18: 666-673. 10.1093/eurpub/ckn063.CrossRefPubMed
17.
go back to reference Bovet P, Junker C, Michel P, Paccaud F: Decreasing stroke and myocardial infarction mortality in a country of the African region. Circulation. 2007, 38 (2): 535. Bovet P, Junker C, Michel P, Paccaud F: Decreasing stroke and myocardial infarction mortality in a country of the African region. Circulation. 2007, 38 (2): 535.
18.
go back to reference Perret F, Bovet P, Shamlaye C, Paccaud F, Kappenberger L: High prevalence of peripheral atherosclerosis in a rapidly developing country. Atherosclerosis. 2000, 153: 9-21. 10.1016/S0021-9150(00)00376-2.CrossRefPubMed Perret F, Bovet P, Shamlaye C, Paccaud F, Kappenberger L: High prevalence of peripheral atherosclerosis in a rapidly developing country. Atherosclerosis. 2000, 153: 9-21. 10.1016/S0021-9150(00)00376-2.CrossRefPubMed
19.
go back to reference Bovet P, Shamlaye C, Kitua A, Riesen WF, Paccaud F, Darioli R: High prevalence of cardiovascular risk factors in the Seychelles (Indian Ocean). Arterioscler Thromb. 1991, 11: 1730-1736.CrossRefPubMed Bovet P, Shamlaye C, Kitua A, Riesen WF, Paccaud F, Darioli R: High prevalence of cardiovascular risk factors in the Seychelles (Indian Ocean). Arterioscler Thromb. 1991, 11: 1730-1736.CrossRefPubMed
20.
go back to reference Bovet P, Shamlaye C, Gabriel A, Riesen W, Paccaud F: Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy. BMC Public Health. 2006, 6: 9-10.1186/1471-2458-6-9.PubMedCentralCrossRefPubMed Bovet P, Shamlaye C, Gabriel A, Riesen W, Paccaud F: Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy. BMC Public Health. 2006, 6: 9-10.1186/1471-2458-6-9.PubMedCentralCrossRefPubMed
21.
go back to reference Statistical abstracts. 2005, Victoria, Seychelles: Management & Information Systems Division Statistical abstracts. 2005, Victoria, Seychelles: Management & Information Systems Division
22.
go back to reference Bovet P, Rosalie D, Shamlaye C, Darioli R, Paccaud F: The Seychelles cardiovascular diseases survey 1989. Soz Praventivmed. 1991, 36 (Suppl 1): S3-S7. 10.1007/BF01318484.CrossRefPubMed Bovet P, Rosalie D, Shamlaye C, Darioli R, Paccaud F: The Seychelles cardiovascular diseases survey 1989. Soz Praventivmed. 1991, 36 (Suppl 1): S3-S7. 10.1007/BF01318484.CrossRefPubMed
24.
go back to reference Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr. 1998, 68: 899-917. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr. 1998, 68: 899-917.
25.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart, Lungand Blood Institute Joint National Committee on, Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289: 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart, Lungand Blood Institute Joint National Committee on, Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289: 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed
26.
go back to reference Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.
27.
go back to reference Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts): European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007, 28: 2375-2414. 10.1093/eurheartj/ehm316.CrossRef Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts): European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007, 28: 2375-2414. 10.1093/eurheartj/ehm316.CrossRef
28.
go back to reference Brunton WA, Steel JM, Percy-Robb IW: An assessment of a reflectance meter system for measurement of plasma or blood glucose in the clinic or side ward. Clin Chim Acta. 1977, 75: 359-364. 10.1016/0009-8981(77)90353-9.CrossRefPubMed Brunton WA, Steel JM, Percy-Robb IW: An assessment of a reflectance meter system for measurement of plasma or blood glucose in the clinic or side ward. Clin Chim Acta. 1977, 75: 359-364. 10.1016/0009-8981(77)90353-9.CrossRefPubMed
29.
go back to reference Shemesh T, Rowley KG, Shephard M, Piers LS, O'Dea K: Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities. Clin Chim Acta. 2006, 367: 69-76. 10.1016/j.cca.2005.11.014.CrossRefPubMed Shemesh T, Rowley KG, Shephard M, Piers LS, O'Dea K: Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities. Clin Chim Acta. 2006, 367: 69-76. 10.1016/j.cca.2005.11.014.CrossRefPubMed
30.
go back to reference Rheney CC, Kirk JK: Performance of three blood glucose meters. Ann Pharmacother. 2000, 34: 317-321. 10.1345/aph.19187.CrossRefPubMed Rheney CC, Kirk JK: Performance of three blood glucose meters. Ann Pharmacother. 2000, 34: 317-321. 10.1345/aph.19187.CrossRefPubMed
31.
go back to reference Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009, 32 (Suppl 1): S62-S67. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009, 32 (Suppl 1): S62-S67.
32.
go back to reference Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN: Insulin deficiency in non-insulin-dependent diabetes. Lancet. 1989, 1: 293-295. 10.1016/S0140-6736(89)91306-8.CrossRefPubMed Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN: Insulin deficiency in non-insulin-dependent diabetes. Lancet. 1989, 1: 293-295. 10.1016/S0140-6736(89)91306-8.CrossRefPubMed
33.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed
34.
go back to reference Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000, 23: 57-63. 10.2337/diacare.23.1.57.CrossRefPubMed Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000, 23: 57-63. 10.2337/diacare.23.1.57.CrossRefPubMed
35.
go back to reference Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K: Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J. 2001, 48: 81-86. 10.1507/endocrj.48.81.CrossRefPubMed Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K: Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J. 2001, 48: 81-86. 10.1507/endocrj.48.81.CrossRefPubMed
36.
go back to reference Mendis S, Lindholm LH, Mancia G, Whitworth J, Alderman M, Lim S, Heagerty T: World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens. 2007, 25: 1578-1582. 10.1097/HJH.0b013e3282861fd3.CrossRefPubMed Mendis S, Lindholm LH, Mancia G, Whitworth J, Alderman M, Lim S, Heagerty T: World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens. 2007, 25: 1578-1582. 10.1097/HJH.0b013e3282861fd3.CrossRefPubMed
37.
go back to reference Prevention of cardiovascular disease. Guidelines for assessment and. management of total cardiovascular risk. 2007, Geneva: World Health Organization Prevention of cardiovascular disease. Guidelines for assessment and. management of total cardiovascular risk. 2007, Geneva: World Health Organization
38.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed
39.
go back to reference Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15: 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed
40.
go back to reference Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M: Age standardization of rates: a new WHO standard. 2005, Geneva: World Health Organization Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M: Age standardization of rates: a new WHO standard. 2005, Geneva: World Health Organization
41.
go back to reference Viswanathan B, Warren CW, Jones NR, Asma S, Bovet P: Linking Global Youth Tobacco Survey (GYTS) data to the WHO Framework Convention on Tobacco Control (FCTC): the case for the Seychelles. Prev Med. 2008, 47 (Suppl 1): S33-S37. 10.1016/j.ypmed.2008.02.008.CrossRefPubMed Viswanathan B, Warren CW, Jones NR, Asma S, Bovet P: Linking Global Youth Tobacco Survey (GYTS) data to the WHO Framework Convention on Tobacco Control (FCTC): the case for the Seychelles. Prev Med. 2008, 47 (Suppl 1): S33-S37. 10.1016/j.ypmed.2008.02.008.CrossRefPubMed
42.
go back to reference Bochud M, Bovet P, Elston RC, Paccaud F, Falconnet C, Maillard M, Shamlaye C, Burnier M: High heritability of ambulatory blood pressure in families of East African descent. Hypertension. 2005, 45: 445-450. 10.1161/01.HYP.0000156538.59873.86.CrossRefPubMed Bochud M, Bovet P, Elston RC, Paccaud F, Falconnet C, Maillard M, Shamlaye C, Burnier M: High heritability of ambulatory blood pressure in families of East African descent. Hypertension. 2005, 45: 445-450. 10.1161/01.HYP.0000156538.59873.86.CrossRefPubMed
43.
go back to reference Critchley J, Liu J, Zhao D, Wei W, Capewell S: Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation. 2004, 110: 1236-1244. 10.1161/01.CIR.0000140668.91896.AE.CrossRefPubMed Critchley J, Liu J, Zhao D, Wei W, Capewell S: Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation. 2004, 110: 1236-1244. 10.1161/01.CIR.0000140668.91896.AE.CrossRefPubMed
45.
go back to reference Bovet P, Faeh D, Gabriel A, Tappy L: The prediction of insulin resistance with serum triglyceride and high-density lipoprotein cholesterol levels in an East African population. Arch Intern Med. 2006, 166: 1236-1237. 10.1001/archinte.166.11.1236-b.CrossRefPubMed Bovet P, Faeh D, Gabriel A, Tappy L: The prediction of insulin resistance with serum triglyceride and high-density lipoprotein cholesterol levels in an East African population. Arch Intern Med. 2006, 166: 1236-1237. 10.1001/archinte.166.11.1236-b.CrossRefPubMed
46.
go back to reference Kelliny C, William J, Riesen W, Paccaud F, Bovet P: Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol. 2008, 7: 27-10.1186/1475-2840-7-27.PubMedCentralCrossRefPubMed Kelliny C, William J, Riesen W, Paccaud F, Bovet P: Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol. 2008, 7: 27-10.1186/1475-2840-7-27.PubMedCentralCrossRefPubMed
47.
go back to reference Faeh D, William J, Tappy L, Ravussin E, Bovet P: Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health. 2007, 7: 163-10.1186/1471-2458-7-163.PubMedCentralCrossRefPubMed Faeh D, William J, Tappy L, Ravussin E, Bovet P: Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health. 2007, 7: 163-10.1186/1471-2458-7-163.PubMedCentralCrossRefPubMed
48.
go back to reference Faeh D, William J, Yerly P, Paccaud F, Bovet P: Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity. Cardiovasc Diabetol. 2007, 6: 32-10.1186/1475-2840-6-32.PubMedCentralCrossRefPubMed Faeh D, William J, Yerly P, Paccaud F, Bovet P: Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity. Cardiovasc Diabetol. 2007, 6: 32-10.1186/1475-2840-6-32.PubMedCentralCrossRefPubMed
49.
go back to reference Grundy SM: Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004, 89: 2595-2600. 10.1210/jc.2004-0372.CrossRefPubMed Grundy SM: Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004, 89: 2595-2600. 10.1210/jc.2004-0372.CrossRefPubMed
50.
go back to reference Ingelsson E, Arnlov J, Sundstrom J, Riserus U, Michaelsson K, Byberg L: Relative importance and conjoint effects of obesity and physical inactivity for the development of insulin resistance. Eur J Cardiovasc Prev Rehabil. 2009, 16: 28-33. 10.1097/HJR.0b013e328319bf8c.CrossRefPubMed Ingelsson E, Arnlov J, Sundstrom J, Riserus U, Michaelsson K, Byberg L: Relative importance and conjoint effects of obesity and physical inactivity for the development of insulin resistance. Eur J Cardiovasc Prev Rehabil. 2009, 16: 28-33. 10.1097/HJR.0b013e328319bf8c.CrossRefPubMed
51.
go back to reference Danon-Hersch N, Chiolero A, Shamlaye C, Paccaud F, Bovet P: Decreasing association between body mass index and blood pressure over time. Epidemiology. 2007, 18: 493-500. 10.1097/EDE.0b013e318063eebf.CrossRefPubMed Danon-Hersch N, Chiolero A, Shamlaye C, Paccaud F, Bovet P: Decreasing association between body mass index and blood pressure over time. Epidemiology. 2007, 18: 493-500. 10.1097/EDE.0b013e318063eebf.CrossRefPubMed
52.
go back to reference Chiolero A, Paradis G, Madeleine G, Hanley JA, Paccaud F, Bovet P: Discordant secular trends in elevated blood pressure and obesity in children and adolescents in a rapidly developing country. Circulation. 2009, 119: 558-565. 10.1161/CIRCULATIONAHA.108.796276.CrossRefPubMed Chiolero A, Paradis G, Madeleine G, Hanley JA, Paccaud F, Bovet P: Discordant secular trends in elevated blood pressure and obesity in children and adolescents in a rapidly developing country. Circulation. 2009, 119: 558-565. 10.1161/CIRCULATIONAHA.108.796276.CrossRefPubMed
53.
go back to reference Flegal KM, Graubard BI, Williamson DF, Gail MH: Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005, 293: 1861-1867. 10.1001/jama.293.15.1861.CrossRefPubMed Flegal KM, Graubard BI, Williamson DF, Gail MH: Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005, 293: 1861-1867. 10.1001/jama.293.15.1861.CrossRefPubMed
54.
go back to reference Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan KM, Williamson DF: Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005, 293: 1868-1874. 10.1001/jama.293.15.1868.CrossRefPubMed Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan KM, Williamson DF: Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005, 293: 1868-1874. 10.1001/jama.293.15.1868.CrossRefPubMed
55.
go back to reference Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005, 165: 2644-2650. 10.1001/archinte.165.22.2644.CrossRefPubMed Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005, 165: 2644-2650. 10.1001/archinte.165.22.2644.CrossRefPubMed
56.
go back to reference Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005, 28: 1769-1778. 10.2337/diacare.28.7.1769.CrossRefPubMed Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005, 28: 1769-1778. 10.2337/diacare.28.7.1769.CrossRefPubMed
57.
go back to reference Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM.: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007, 49: 403-414. 10.1016/j.jacc.2006.09.032.CrossRefPubMed Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM.: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007, 49: 403-414. 10.1016/j.jacc.2006.09.032.CrossRefPubMed
58.
go back to reference Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lennon L, Macfarlane PW, Murphy MB, Packard CJ, Stott DJ, Westendorp RG, Whincup PH, Shepherd J, Wannamethee SG.: Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008, 371: 1927-1935. 10.1016/S0140-6736(08)60602-9.CrossRefPubMed Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lennon L, Macfarlane PW, Murphy MB, Packard CJ, Stott DJ, Westendorp RG, Whincup PH, Shepherd J, Wannamethee SG.: Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008, 371: 1927-1935. 10.1016/S0140-6736(08)60602-9.CrossRefPubMed
59.
go back to reference O'Flaherty M, Ford E, Allender S, Scarborough P, Capewell S: Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart. 2008, 94: 178-181. 10.1136/hrt.2007.118323.CrossRefPubMed O'Flaherty M, Ford E, Allender S, Scarborough P, Capewell S: Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart. 2008, 94: 178-181. 10.1136/hrt.2007.118323.CrossRefPubMed
60.
go back to reference Rose G: Incubation period of coronary heart disease. 1982. Int J Epidemiol. 2005, 34: 242-244. 10.1093/ije/dyh308.CrossRefPubMed Rose G: Incubation period of coronary heart disease. 1982. Int J Epidemiol. 2005, 34: 242-244. 10.1093/ije/dyh308.CrossRefPubMed
61.
go back to reference Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004, 291: 335-342. 10.1001/jama.291.3.335.CrossRefPubMed Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004, 291: 335-342. 10.1001/jama.291.3.335.CrossRefPubMed
62.
go back to reference Bovet P, Gervasoni JP, Ross AG, Mkamba M, Mtasiwa DM, Lengeler C, Bovet P, Gervasoni JP, Ross AG, Mkamba M, Mtasiwa DM, Lengeler C: Assessing the prevalence of hypertension in populations: are we doing it right?. J Hypertens. 2003, 21: 509-517. 10.1097/00004872-200303000-00016.CrossRefPubMed Bovet P, Gervasoni JP, Ross AG, Mkamba M, Mtasiwa DM, Lengeler C, Bovet P, Gervasoni JP, Ross AG, Mkamba M, Mtasiwa DM, Lengeler C: Assessing the prevalence of hypertension in populations: are we doing it right?. J Hypertens. 2003, 21: 509-517. 10.1097/00004872-200303000-00016.CrossRefPubMed
63.
go back to reference Luepker RV: Decline in incident coronary heart disease: why are the rates falling?. Circulation. 2008, 117: 592-593. 10.1161/CIRCULATIONAHA.107.747477.CrossRefPubMed Luepker RV: Decline in incident coronary heart disease: why are the rates falling?. Circulation. 2008, 117: 592-593. 10.1161/CIRCULATIONAHA.107.747477.CrossRefPubMed
64.
go back to reference Rodriguez T, Malvezzi M, Chatenoud L, Bosetti C, Levi F, Negri E, La Vecchia C: Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970–2000. Heart. 2006, 92: 453-460. 10.1136/hrt.2004.059295.PubMedCentralCrossRefPubMed Rodriguez T, Malvezzi M, Chatenoud L, Bosetti C, Levi F, Negri E, La Vecchia C: Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970–2000. Heart. 2006, 92: 453-460. 10.1136/hrt.2004.059295.PubMedCentralCrossRefPubMed
65.
go back to reference Bovet P, Shamlaye H, Paccaud F: Epidemiology and prevention of cardiovascular disease in the Seychelles islands (Indian Ocean). CVD Prevention. 1999, 2: 261-272. Bovet P, Shamlaye H, Paccaud F: Epidemiology and prevention of cardiovascular disease in the Seychelles islands (Indian Ocean). CVD Prevention. 1999, 2: 261-272.
66.
go back to reference Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R: Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007, 370: 2044-2053. 10.1016/S0140-6736(07)61698-5.CrossRefPubMed Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R: Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007, 370: 2044-2053. 10.1016/S0140-6736(07)61698-5.CrossRefPubMed
67.
go back to reference Gaziano TA, Galea G, Reddy KS: Scaling up interventions for chronic disease prevention: the evidence. Lancet. 2007, 370: 1939-1946. 10.1016/S0140-6736(07)61697-3.CrossRefPubMed Gaziano TA, Galea G, Reddy KS: Scaling up interventions for chronic disease prevention: the evidence. Lancet. 2007, 370: 1939-1946. 10.1016/S0140-6736(07)61697-3.CrossRefPubMed
68.
go back to reference Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R, Rodgers A: Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet. 2007, 370: 2054-2062. 10.1016/S0140-6736(07)61699-7.CrossRefPubMed Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R, Rodgers A: Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet. 2007, 370: 2054-2062. 10.1016/S0140-6736(07)61699-7.CrossRefPubMed
69.
go back to reference Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008, 93: S9-30. 10.1210/jc.2008-1595.CrossRefPubMed Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008, 93: S9-30. 10.1210/jc.2008-1595.CrossRefPubMed
70.
go back to reference Hossain P, Kawar B, El Nahas M: Obesity and diabetes in the developing world – a growing challenge. N Engl J Med. 2007, 356: 213-215. 10.1056/NEJMp068177.CrossRefPubMed Hossain P, Kawar B, El Nahas M: Obesity and diabetes in the developing world – a growing challenge. N Engl J Med. 2007, 356: 213-215. 10.1056/NEJMp068177.CrossRefPubMed
71.
go back to reference Katan MB: Weight-loss diets for the prevention and treatment of obesity. N Engl J Med. 2009, 360: 923-925. 10.1056/NEJMe0810291.CrossRefPubMed Katan MB: Weight-loss diets for the prevention and treatment of obesity. N Engl J Med. 2009, 360: 923-925. 10.1056/NEJMe0810291.CrossRefPubMed
72.
go back to reference Byberg L, Melhus H, Gedeborg R, Sundstrom J, Ahlbom A, Zethelius B, Berglund LG, Wolk A, Michaëlsson K: Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ. 2009, 338: b688-10.1136/bmj.b688.PubMedCentralCrossRefPubMed Byberg L, Melhus H, Gedeborg R, Sundstrom J, Ahlbom A, Zethelius B, Berglund LG, Wolk A, Michaëlsson K: Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ. 2009, 338: b688-10.1136/bmj.b688.PubMedCentralCrossRefPubMed
73.
go back to reference Kumanyika SK, Obarzanek E, Stettler N, Bell R, Field AE, Fortmann SP, Franklin BA, Gillman MW, Lewis CE, Poston WC, Stevens J, Hong Y, American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention: Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the expert panel on population and prevention science). Circulation. 2008, 118: 428-464. 10.1161/CIRCULATIONAHA.108.189702.CrossRefPubMed Kumanyika SK, Obarzanek E, Stettler N, Bell R, Field AE, Fortmann SP, Franklin BA, Gillman MW, Lewis CE, Poston WC, Stevens J, Hong Y, American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention: Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the expert panel on population and prevention science). Circulation. 2008, 118: 428-464. 10.1161/CIRCULATIONAHA.108.189702.CrossRefPubMed
74.
go back to reference Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases 2008–2013. 2008, Geneva: World Health Organization Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases 2008–2013. 2008, Geneva: World Health Organization
75.
go back to reference Gidding SS, Lichtenstein AH, Faith MS, Karpyn A, Mennella JA, Popkin B, Rowe J, Van Horn L, Whitsel L: Implementing American Heart Association pediatric and adult nutrition guidelines: a scientific statement from the American Heart Association Nutrition Committee of the council on nutrition, physical activity and metabolism, council on cardiovascular disease in the young, council on arteriosclerosis, thrombosis and vascular biology, council on cardiovascular nursing, council on epidemiology and prevention, and council for high blood pressure research. Circulation. 2009, 119: 1161-1175. 10.1161/CIRCULATIONAHA.109.191856.CrossRefPubMed Gidding SS, Lichtenstein AH, Faith MS, Karpyn A, Mennella JA, Popkin B, Rowe J, Van Horn L, Whitsel L: Implementing American Heart Association pediatric and adult nutrition guidelines: a scientific statement from the American Heart Association Nutrition Committee of the council on nutrition, physical activity and metabolism, council on cardiovascular disease in the young, council on arteriosclerosis, thrombosis and vascular biology, council on cardiovascular nursing, council on epidemiology and prevention, and council for high blood pressure research. Circulation. 2009, 119: 1161-1175. 10.1161/CIRCULATIONAHA.109.191856.CrossRefPubMed
76.
go back to reference Romon M, Lommez A, Tafflet M, Basdevant A, Oppert JM, Bresson JL, Ducimetière P, Charles MA, Borys JM: Downward trends in the prevalence of childhood overweight in the setting of 12-year school- and community-based programmes. Public Health Nutr. 2008, 1-8. 10.1017/S1368980008004278. Romon M, Lommez A, Tafflet M, Basdevant A, Oppert JM, Bresson JL, Ducimetière P, Charles MA, Borys JM: Downward trends in the prevalence of childhood overweight in the setting of 12-year school- and community-based programmes. Public Health Nutr. 2008, 1-8. 10.1017/S1368980008004278.
Metadata
Title
Divergent fifteen-year trends in traditional and cardiometabolic risk factors of cardiovascular diseases in the Seychelles
Authors
Pascal Bovet
Sarah Romain
Conrad Shamlaye
Shanti Mendis
Roger Darioli
Walter Riesen
Luc Tappy
Fred Paccaud
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2009
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-8-34

Other articles of this Issue 1/2009

Cardiovascular Diabetology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine